Influence of genetic polymorphisms in DICER and XPO5 genes on the risk of coronary artery disease and circulating levels of vascular miRNAs

被引:9
|
作者
Borghini, Andrea [1 ]
Pulignani, Silvia [1 ]
Mercuri, Antonella [1 ]
Vecoli, Cecilia [1 ]
Turchi, Stefano [1 ]
Carpeggiani, Clara [1 ]
Andreassi, Maria Grazia [1 ]
机构
[1] CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy
关键词
microRNA; DICERrs1057035 T > C; XPO5 rs11077 A > C; Coronary artery disease; MICRORNA PROCESSING GENES;
D O I
10.1016/j.thromres.2019.05.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Single-nucleotide polymorphisms (SNPs) in microRNA (miRNA) machinery genes may affect the regulatory capacity of miRNAs by impacting their biogenesis. The aim of the study was to analyze the association between SNPs in two key genes (DICER rs1057035T > C and XPO5 rs11077A > C) and coronary artery disease (CAD) risk as well as to examine their effects on circulating levels of vascular miRNAs. Materials and methods: Within the Italian GENOCOR cohort, we studied a cohort of 557 patients (502 males, 57 +/- 9 years) with angiographically documented CAD. A total of 443 healthy controls (262 males, 56 +/- 12 years) was also enrolled. Genotyping was determined by using a TaqMan (R) SNP genotyping assay. Analysis of miR-132 and miR-140-3p was assessed in a subset of 70 CAD patients by using qRT-PCR. Results: There were statistically significant differences between CAD patients and healthy controls in the distribution of both DICER and XPO5 genotypes (p = 0.03 and p = 0.02, respectively). Multivariate analysis showed a significantly decreased risk of CAD by 50% in patients with DICER rs105703CC genotype as compared to TC heterozygote and TT homozygote patients (ORadjusted = 0.50; CI: 0.30-0.83, p = 0.007). In a recessive model, the XPO5 rs11077CC genotype was associated with a 32% reduced risk of CAD (ORadjusted = 0.68; CI: 0.30-0.99 p = 0.047). XPO5 rs11077CC genotype was significantly associated with higher levels of both miRNA-132 (p = 0.04) and miRNA-140-3p (p = 0.03). Conclusions: Genetic polymorphisms in DICER and XPO5 genes are associated with a decreased risk of CAD, probably by impacting expression levels of vascular and cardiac-specific miRNAs. Further studies are needed to better elucidate the biological relevance of both variants in CAD development.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 50 条
  • [31] Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease
    Duraid Hamid Naji
    Chengcheng Tan
    Fabin Han
    Yuanyuan Zhao
    Junhan Wang
    Dan Wang
    Jingjing Fa
    Sisi Li
    Shanshan Chen
    Qiuyun Chen
    Chengqi Xu
    Qing K. Wang
    Molecular Genetics and Genomics, 2018, 293 : 119 - 128
  • [32] LDLR, ApoB and ApoE genes polymorphisms and classical risk factors in premature coronary artery disease
    Abd El-Aziz, Tarek A.
    Mohamed, Randa H.
    GENE, 2016, 590 (02) : 263 - 269
  • [33] Apolipoprotein A5 polymorphisms and risk of coronary artery disease: A meta-analysis
    Zhang, Zhen
    Peng, Bo
    Gong, Renrong
    Gao, Linbo
    Du, Juan
    Fang, Dingzhi
    Song, Yongyan
    Li, Yuanhao
    Ou, Guojing
    BIOSCIENCE TRENDS, 2011, 5 (04) : 165 - 172
  • [34] Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta analysis
    Ma, Wen-Qi
    Wang, Ying
    Han, Xi-Qiong
    Zhu, Yi
    Liu, Nai-Feng
    BMC MEDICAL GENETICS, 2018, 19
  • [35] Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease
    Lingenhel, Arno
    Kollerits, Barbara
    Schwaiger, Johannes P.
    Hunt, Steven C.
    Gress, Richard
    Hopkins, Paul N.
    Schoenborn, Veit
    Heid, Iris M.
    Kronenberg, Florian
    EXPERIMENTAL GERONTOLOGY, 2008, 43 (12) : 1102 - 1107
  • [36] Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease
    BiHong Liao
    KeQi Cheng
    ShaoHong Dong
    HuaDong Liu
    ZhengLei Xu
    Diagnostic Pathology, 10
  • [37] Polymorphisms in platelet glycoprotein Ib alpha as a genetic risk factor for coronary artery disease.
    Matsubara, Y
    Murata, M
    Kawano, K
    Zama, T
    Aoki, N
    Yoshino, H
    Watanabe, G
    Ishikawa, K
    Ikeda, Y
    BLOOD, 1997, 90 (10) : 675 - 675
  • [38] Genetic burden of polymorphisms related to lipid metabolism increases the risk of angiographic coronary artery disease
    Horne, BD
    Anderson, JL
    Muhlestein, JB
    Renlund, DG
    Maycock, CAA
    Reyna, SP
    King, CA
    Whiting, BM
    Chaichana, K
    Carlquist, JF
    CIRCULATION, 2002, 106 (19) : 727 - 727
  • [39] Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease
    Liao, BiHong
    Cheng, KeQi
    Dong, ShaoHong
    Liu, HuaDong
    Xu, ZhengLei
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [40] Circulating sclerostin levels are positively related to coronary artery disease severity and related risk factors
    Frysz, Monika
    Gergei, Ingrid
    Scharnag, Hubert
    Smith, George Davey
    Zheng, Jie
    Lawlor, Deborah
    Herrmann, Markus
    Maerz, Winfried
    Tobias, Jon
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 64 - 64